CRG/UPF Proteomics Unit
- Unit page
- Services & Equipment
- Unit members
- Publications at CRG
The goal of the Proteomics Unit is to provide proteomic services to internal and external users, and to further develop mass spectrometry-based quantitative techniques so that proteomics becomes a set of robust, sensitive, accurate and precise methods that enable not only the generation of research hypotheses but also their subsequent validation in complex biological systems.
The Unit is involved in several international collaborations both with individual researchers and research initiaves and consortia, and it has been part of the European Project PrimeXS infrastructure that gathered together the best European proteomics laboratories and platforms to spread proteomics access and tools to the international community. Moreover, the Proteomics Unit is also part of the "Plataforma de Recursos Biomoleculares y Bioinformáticos" and "ProteoRed" of the Instituto de Salud Carlos III, part of the Spanish National Health System.
New public-private initiative to develop a new therapy against aterosclerosis (27/01/2017)
The project - which has just received 700,000 euros in the Spanish 2016 Retos-Colaboracion call- is led by biotech Iproteos, based at the Parc Cientific de Barcelona, with the participation of the Biomedical Research Institute of Barcelona (IIBB- CSIC) and the Centre for Genomic Regulation (CRG).
A short jump from single-celled ancestors to animals (13/10/2016)
The first animals evolved from their single-celled ancestors around 800 million years ago, but new evidence suggests that this leap to multi-celled organisms in the tree of life may not have been quite as dramatic as scientists once assumed.
New tools for the diagnosis of multiple sclerosis in its early stages (14/01/2016)
Scientists at the Centre for Genomic Regulation (CRG) and the Vall d'Hebron Research Institute (VHIR) develop a new method for early diagnosis of the disease.
BRAND NEW: The CRG/UPF Proteomics Unit is the first European facility to get the newest tri-hibrid mass spectometer (25/06/2015)
Launched internationally last week during the 63rd Annual American Society for Mass Spectrometry Conference in Saint Louis (US), the top-class Orbitrap Fusion Lumos from Thermo Fisher Scientific hast just been installed in the CRG/UPF Proteomics Unit.
Eduard Sabidó CV
2006 Short Term Fellowship at The Scripps Research Institute, San Diego, USA.
2008 PhD in Biology at the University of Barcelona, Barcelona, Spain.
2009-2012 Postdoctoral fellow at Swiss Federal Institute of Technology of Zurich (ETHZ), Zürich, Switzerland.
2012- Head of the CRG/UPF Proteomics Core Facility at the Centre for Genomic Regulation (CRG), Barcelona, Spain.
The facility is involved in the project "Desarrollo de una terapia innovadora para el tratamiento de la aterosclerosis mediante la inhibición de la acumulación vascular de colesterol", co-funded by the Spanish Ministry of Economy, Industry and Competitiveness and European Regional Development Funds (reference RTC-2016-5078-1).